← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biopeptides, Inc.
East Setauket, NY
$13,562,221
Total funding
14
Grants
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,562,221 · 14
By mechanism
R44$9,506,168 · 5
R43$3,469,974 · 8
R41$586,079 · 1
Investigators at Biopeptides, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$1,000,000
R44 · FY2021 · AI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$986,480
R44 · FY2022 · AI
A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.$971,664
R44 · FY2024 · AI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$971,240
R44 · FY2023 · AI
A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.$962,204
R44 · FY2025 · AI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$727,043
R44 · FY2010 · AI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$719,308
R44 · FY2011 · AI
Development of a cytokine release assay for the diagnosis of Lyme disease$605,367
R44 · FY2017 · AI
Development of a cytokine release assay for the diagnosis of Lyme disease$605,367
R44 · FY2016 · AI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$583,580
R44 · FY2009 · AI
WILDLIFE ORAL VACCINE AGAINST B. BURGDORFERI$437,219
R44 · FY2005 · AI
WILDLIFE ORAL VACCINE AGAINST B. BURGDORFERI$423,449
R44 · FY2006 · AI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$300,000
R43 · FY2012 · AI
Development of an Antigen Capture Assay for Babesia microti$300,000
R41 · FY2014 · AI
Development of a Cytokine Release Assay as a Diagnostic Test for Lyme Disease$300,000
R43 · FY2013 · AI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$300,000
R44 · FY2020 · AI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$300,000
R43 · FY2011 · AI
Development of a Cytokine Release Assay as a Diagnostic Test for Lyme Disease$300,000
R43 · FY2012 · AI
BAIT VACCINE AGAINST LYME BORRELIOSIS$299,997
R43 · FY2008 · AI
BAIT VACCINE AGAINST LYME BORRELIOSIS$299,996
R43 · FY2007 · AI